Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

MediWound (MDWD) Other Non Operating Income (2016 - 2025)

MediWound has reported Other Non Operating Income over the past 10 years, most recently at $17000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 194.44% year-over-year to $17000.0; the TTM value through Dec 2025 reached $3.9 million, up 156.4%, while the annual FY2025 figure was $13000.0, 172.22% up from the prior year.
  • Other Non Operating Income for Q4 2025 was $17000.0 at MediWound, down from $3.9 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $4.9 million in Q2 2023 and troughed at -$5.2 million in Q3 2024.
  • A 5-year average of $117950.0 and a median of $38500.0 in 2022 define the central range for Other Non Operating Income.
  • Biggest five-year swings in Other Non Operating Income: skyrocketed 1643.82% in 2023 and later plummeted 7717.65% in 2024.
  • Year by year, Other Non Operating Income stood at $101000.0 in 2021, then plummeted by 40.59% to $60000.0 in 2022, then tumbled by 675.0% to -$345000.0 in 2023, then surged by 94.78% to -$18000.0 in 2024, then surged by 194.44% to $17000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for MDWD at $17000.0 in Q4 2025, $3.9 million in Q3 2025, and -$6000.0 in Q2 2025.